Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical Features and Risk Factors of Post-Engraftment Bloodstream Infection in Allogeneic HCT

Tatsuya Suwabe, MD, Kyoko Fuse, MD, Takayuki Katagiri, MD, Tomoyuki Tanaka, MD PhD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2018) 132 (Supplement 1): 5712.

https://doi.org/10.1182/blood-2018-99-115844

Published: 2018

Journal Articles

A Prospective Initiative to Reduce Mucosal Barrier Injuries and Blood Stream Infections in Patients with Hematologic Malignancy Receiving Inpatient Chemotherapy

Daniel R Reed, MD, Katie E Ruefer, RN, Tanya D Thomas, RN, Erin L Harr, RN, Elizabeth R Daniels, RN, Jeremy M Sen, PharmD, BCOP, Michael K Keng, MD

Blood (2018) 132 (Supplement 1): 5896.

https://doi.org/10.1182/blood-2018-99-112598

Published: 2018

Journal Articles

Pralatrexate: Phase 1/2 Study in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)

Yoshinobu Maeda, MD PhD, Kensei Tobinai, MD, PhD, Hirokazu Nagai, MD PhD, Takahiko Nakane, MD, PhD, Tatsu Shimoyama, MD, Tomonori Nakazato, Rika Sakai, Takayuki Ishikawa, MD, PhD, Koji Izutsu, MD PhD, Ryuzo Ueda, MD PhD

Blood (2016) 128 (22): 4157.

https://doi.org/10.1182/blood.V128.22.4157.4157

Published: 2016

Journal Articles

Oral Cryotherapy For The Prevention Of Mucositis Following Myeloablative Conditioning and Hematopoietic Stem Cell Transplantation

Yin Lu, Xiaming Zhu, Wu Depei

Blood (2013) 122 (21): 5466.

https://doi.org/10.1182/blood.V122.21.5466.5466

Published: 2013

Journal Articles

Unexpected 5 Year Survival Benefit in Patients Given Oral Cryotherapy During Conditioning for Stem Cell Transplantation. A Prospective Randomized Study

Anncarin Svanberg, Kerstin Öhrn, Gunnar Birgegard, MD, PhD

Blood (2011) 118 (21): 4559.

https://doi.org/10.1182/blood.V118.21.4559.4559

Published: 2011

NARROW

Clinical Features and Risk Factors of Post-Engraftment Bloodstream Infection in Allogeneic HCT

A Prospective Initiative to Reduce Mucosal Barrier Injuries and Blood Stream Infections in Patients with Hematologic Malignancy Receiving Inpatient Chemotherapy

Pralatrexate: Phase 1/2 Study in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)

Oral Cryotherapy For The Prevention Of Mucositis Following Myeloablative Conditioning and Hematopoietic Stem Cell Transplantation

Unexpected 5 Year Survival Benefit in Patients Given Oral Cryotherapy During Conditioning for Stem Cell Transplantation. A Prospective Randomized Study

Email alerts

ASH Publications

American Society of Hematology

Clinical Features and Risk Factors of Post-Engraftment Bloodstream Infection in Allogeneic HCT

A Prospective Initiative to Reduce Mucosal Barrier Injuries and Blood Stream Infections in Patients with Hematologic Malignancy Receiving Inpatient Chemotherapy

Pralatrexate: Phase 1/2 Study in Japanese Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL)

Oral Cryotherapy For The Prevention Of Mucositis Following Myeloablative Conditioning and Hematopoietic Stem Cell Transplantation

Unexpected 5 Year Survival Benefit in Patients Given Oral Cryotherapy During Conditioning for Stem Cell Transplantation. A Prospective Randomized Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only